Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Lipocine to Present at the Ladenburg Thalmann 2018 Healthcare Conference
Tuesday, October 2, 2018
12:00pm - 12:25pm EDT
Venue
Track 6 – Madeleine Room